The Effect of SYT-SSX and Extracellular Signal-Regulated Kinase (ERK) on Cell Proliferation in Synovial Sarcoma
Authors:
- 14 January 2011
- journal article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 17 (2) , 357-367
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- RETRACTED: A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cellsThe International Journal of Biochemistry & Cell Biology, 2009
- Loss of p27 Expression Through RAS->BRAF->MAP Kinase-Dependent Pathway in Human Thyroid CarcinomasCell Cycle, 2007
- Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progressionGynecologic Oncology, 2007
- Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in ratsJournal of Hepatology, 2006
- Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target geneOncogene, 2003
- Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1Biochemical Journal, 2002
- SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.2002
- Association of SYT-SSX Fusion Types with Proliferative Activity and Prognosis in Synovial SarcomaLaboratory Investigation, 2000
- Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.2000
- Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomaNature Genetics, 1994